JOHNSON & JOHNSON Accounts Receivable 2008-2026 | JNJ
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is JOHNSON & JOHNSON's current accounts receivable?
JOHNSON & JOHNSON (JNJ) annual accounts receivable for 2025 was $17.18B, a 15.74% increase from 2024. JOHNSON & JOHNSON accounts receivable for the quarter ending March 29, 2026 was $17.72B.
What was JOHNSON & JOHNSON's accounts receivable in 2024?
JOHNSON & JOHNSON annual accounts receivable for 2024 was $14.84B, a 0.21% decline from 2023.
What was JOHNSON & JOHNSON's accounts receivable in 2023?
JOHNSON & JOHNSON annual accounts receivable for 2023 was $14.87B, a 2.68% decline from 2022.
What is JOHNSON & JOHNSON's 4-year accounts receivable CAGR?
JOHNSON & JOHNSON accounts receivable grew at a compound annual growth rate (CAGR) of 6.06% from FY2021 to FY2025, going from $13.58B to $17.18B over 4 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.5%
FY2019
$14.48B
→
FY2025
$17.18B
081011121314161718192122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $17.18B | +15.7% | 10-K |
| FY2024 | $14.84B | -0.2% | 10-K |
| FY2023 | $14.87B | -2.7% | 10-K |
| FY2022 | $15.28B | +12.6% | 10-K |
| FY2021 | $13.58B | -6.2% | 10-K |
| FY2019 | $14.48B | +2.7% | 10-K |
| FY2018 | $14.10B | +4.5% | 10-K |
| FY2017 | $13.49B | +25.7% | 10-K |
| FY2016 | $10.73B | -2.3% | 10-K |
| FY2014 | $10.98B | -6.2% | 10-K |
| FY2013 | $11.71B | +3.6% | 10-K |
| FY2012 | $11.31B | +15.7% | 10-K |
| FY2011 | $9.77B | +1.3% | 10-K |
| FY2010 | $9.65B | -0.8% | 10-K |
| FY2008 | $9.72B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →